Results 211 to 220 of about 5,053,828 (347)

[Digitalization and access as a means of responding to health care practices: from Adolescence to Old Age] [PDF]

open access: yesRev Fac Cien Med Univ Nac Cordoba
Gutierrez Quiceno B   +2 more
europepmc   +1 more source

Ingreso neonatal en alojamiento conjunto: efecto sobre la lactancia materna durante los 6 primeros meses de vida

open access: diamond
Lorena Suárez   +6 more
openalex   +2 more sources

Experiência de famílias e terapeutas com um programa de telessaúde para crianças e adolescentes com paralisia cerebral durante a pandemia de COVID‐19

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
Experiências de pais de crianças com paralisia cerebral e terapeutas no programa individualizado. Resumo Objetivo Compreender as percepções das famílias e terapeutas sobre a sua participação em um programa domiciliar individualizado via telessaúde implementado para crianças e adolescentes com paralisia cerebral (PC) durante a pandemia da COVID‐19 no ...
Rachel Oliveira   +5 more
wiley   +1 more source

Bexicaserin for the treatment of seizures in developmental and epileptic encephalopathies: A phase 1b/2a trial (PACIFIC)

open access: yesEpilepsia, EarlyView.
Abstract Objective This randomized, double‐blind, phase 1b/2a clinical trial was designed to evaluate the safety, tolerability, and efficacy of oral bexicaserin versus placebo for the treatment of seizures in adolescents and adults with developmental and epileptic encephalopathies (DEEs).
Dennis J. Dlugos   +74 more
wiley   +1 more source

The influence of lifestyle habits on the perception of vestibular symptoms in patients with heart failure. [PDF]

open access: yesCodas
Araújo FLKL   +5 more
europepmc   +1 more source

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow   +3 more
wiley   +1 more source

QUALIDADE DE VIDA DE IDOSOS RESIDENTES EM MORADIA ESPECÍFICA

open access: gold, 2020
Gilvaneide Rodrigues Vitorino Moura   +3 more
openalex   +1 more source

A phase 1, multicenter, open‐label study to evaluate the pharmacokinetics, safety, and tolerability of a single dose of rimegepant in children (aged ≥6 to <12 years) with a history of migraine

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To evaluate pharmacokinetics (PK), safety, and tolerability of a weight‐adjusted dose of rimegepant orally disintegrating tablet (ODT) in children (aged ≥6 to <12 years) with a history of migraine. Background Rimegepant 75 mg ODT is approved for acute treatment of migraine (with or without aura) and preventive treatment of episodic ...
Chay Ngee Lim   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy